IPW
ABBV icon

Impact Partnership Wealth’s AbbVie ABBV Stock Holding History

Impact Partnership Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
5,512
+3,872
+236% +$833K 0.13% 107
2026
Q1 		$357K Buy
1,640
+41
+3% +$9.1K 0.04% 248
2025
Q4 		$365K Buy
1,599
+546
+52% +$124K 0.05% 250
2025
Q3 		$244K Sell
1,053
-2,556
-71% -$520K 0.04% 257
2025
Q2 		$670K Buy
+3,609
New +$671K 0.12% 96
2025
Q1 		– Sell
-4,842
Closed -$860K – 260
2024
Q4 		$860K Sell
4,842
-754
-13% -$139K 0.17% 66
2024
Q3 		$1.11M Sell
5,596
-72
-1% -$13.4K 0.25% 45
2024
Q2 		$972K Buy
5,668
+4,982
+726% +$825K 0.26% 49
2024
Q1 		$125K Sell
686
-5,126
-88% -$883K 0.05% 229
2023
Q4 		$901K Buy
5,812
+1,365
+31% +$199K 0.33% 35
2023
Q3 		$663K Buy
4,447
+301
+7% +$44.2K 0.21% 52
2023
Q2 		$559K Buy
+4,146
New +$608K 0.19% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Impact Partnership Wealth's ABBV Position: Q2 2026 in Review

Impact Partnership Wealth increased its AbbVie (ABBV) stake by 236% in Q2 2026, buying an estimated $833K and bringing the position to 5,512 shares worth $1.39M. The position accounts for 0.13% of the portfolio, ranked #107.

Impact Partnership Wealth first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. 4,227 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Impact Partnership Wealth held 5,512 shares of AbbVie worth $1.39M as of Q2 2026.
  • Impact Partnership Wealth bought 3,872 AbbVie shares in Q2 2026, an estimated $833K.
  • AbbVie made up 0.13% of Impact Partnership Wealth's portfolio in Q2 2026, its #107 holding.
  • Impact Partnership Wealth first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
  • 4,227 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Impact Partnership Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.